Completed Patheon and DSM Merger Forms New Powerhouse CMO
DPx - the result of a $2.65 billion transaction between JLL Partners and Royal DSM announced in November - officially launched on Tuesday, as a leading global contract development and manufacturing organization (CDMO) for the pharmaceutical and related industries.
Formerly known by its provisional name “NewCo,” DPx is the corporate parent of a group of business units that is comprised of three distinct brands focused on pharmaceutical services, fine chemicals and products and proprietary technologies. These units are the result of combining DSM Pharmaceutical Products (DPP), Patheon and Banner Life Sciences.
With global headquarters in Durham, N.C., DPx has a footprint of 24 locations across North America, Europe, Latin America and Australia, with more than 8,000 employees. DPx’s 2014 sales are anticipated to be about $2 billion.
Read the Patheon announcement